Glycogen storage disease due to phosphorylase kinase deficiency

Glycogen storage disease due to phosphorylase kinase (PhK) deficiency encompasses a group of inherited metabolic disorders caused by deficiency of the enzyme phosphorylase kinase, which plays a critical role in glycogen breakdown (glycogenolysis). Phosphorylase kinase is a complex enzyme composed of four subunits (alpha, beta, gamma, and delta), each encoded by different genes on different chromosomes. Depending on which subunit gene is affected, the condition can follow X-linked recessive or autosomal recessive inheritance. The most common form is X-linked liver phosphorylase kinase deficiency (GSD type IXa), caused by mutations in the PHKA2 gene, which primarily affects the liver. Other forms can affect skeletal muscle, heart, or multiple tissues simultaneously. The disease primarily affects the liver and/or skeletal muscles, depending on the subtype. In the liver forms, children typically present in early childhood with hepatomegaly (enlarged liver), growth retardation, elevated liver transaminases, hyperlipidemia, fasting hypoglycemia, and fasting ketosis. Liver symptoms often improve with age, and many patients have a relatively benign course compared to other glycogen storage diseases. In the muscle forms, patients may experience exercise intolerance, muscle cramps, pain, weakness, and occasionally myoglobinuria. Some rare subtypes can involve cardiac muscle, leading to cardiomyopathy. A combined liver and muscle form also exists. There is currently no specific cure for phosphorylase kinase deficiency. Management is primarily supportive and depends on the subtype. For liver forms, treatment focuses on dietary management including frequent meals, complex carbohydrates, and avoidance of prolonged fasting to prevent hypoglycemia. Cornstarch supplementation may be used to maintain blood glucose levels. For muscle forms, avoidance of strenuous exercise and dietary modifications may help manage symptoms. Prognosis is generally favorable for the common liver form, with many patients experiencing improvement of hepatomegaly and growth normalization by adulthood. Regular monitoring of liver function, growth parameters, and metabolic status is recommended.

Common questions about Glycogen storage disease due to phosphorylase kinase deficiency